| Bioactivity | TYVPANASL is a MHC I-binding CD8 T cell epitope of nine amino acids from HER2/neu. TYVPANASL can be used to prepare J-LEAPS vaccine[1]. |
| Name | TYVPANASL |
| CAS | 921621-38-7 |
| Sequence | Thr-Tyr-Val-Pro-Ala-Asn-Ala-Ser-Leu |
| Shortening | TYVPANASL |
| Formula | C42H66N10O14 |
| Molar Mass | 935.03 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Ken S Rosenthal, et al. LEAPS Vaccine Incorporating HER-2/neu Epitope Elicits Protection That Prevents and Limits Tumor Growth and Spread of Breast Cancer in a Mouse Model. J Immunol Res. 2017;2017:3613505. |
TYVPANASL
CAS: 921621-38-7 F: C42H66N10O14 W: 935.03
TYVPANASL is a MHC I-binding CD8 T cell epitope of nine amino acids from HER2/neu. TYVPANASL can be used to prepare J-LE
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.